Dr. Patrick Soon-Shiong

Patrick Soon-Shiong, MD, is Chairman of NantEnergy and Chairman and CEO of its parent company, NantWorks, LLC. He is a physician, surgeon, scientist, inventor, technologist and philanthropist who has devoted his career to creating innovations with the potential to have global impact. With the founding of NantEnergy, he is leading a worldwide effort to provide clean energy solutions that benefit people, business and the planet.
NantEnergy designs, manufactures and markets innovative and intelligent energy storage solutions that are fundamentally changing the way people, businesses and utilities generate, store and use electricity. Based on innovative zinc-air rechargeable battery technology, NantEnergy solutions cost less, last longer and are far more environmentally friendly than lead-acid batteries and diesel generators. NantEnergy systems serve as the core of distributed commercial and industrial energy management systems, remote microgrids and reliable backup power to critical wireless infrastructure.
Coupled with renewable energy generation such as solar panels, this technology is the sole source of power for more than 200,000 people in villages across rural Indonesia and Africa, providing many of them with access to electricity for the first time. It has replaced one million toxic lead-acid batteries and eliminated the need to consume four million liters of diesel fuel.
That same technology gives NantEnergy’s commercial and industrial customers significant reductions in their electricity costs, in many cases eliminating demand charges entirely.
Over the course of Dr. Soon-Shiong's career, he has pioneered novel therapies for both diabetes and cancer, including the revolutionary cancer drug Abraxane. He has published more than 100 scientific papers and has been granted more than 230 patents worldwide for groundbreaking advancements spanning myriad fields of technology and medicine.
He was a researcher for NASA, leaving in 1991 to form his first biotech company. From 1996 to 2010, he served as Founder, Chairman and CEO of two global pharmaceutical companies. In 2010, after the sale of both companies, he established NantWorks, LLC, an ecosystem of companies with deep understandings in a wide variety of complex industries, from science to data, communication and mobility.
In addition to his businesses, Dr. Soon-Shiong also holds the position of Adjunct Professor of Surgery at the University of California, Los Angeles (UCLA), a visiting Professor at the Imperial College of London, the Executive Director of the UCLA Wireless Health Institute and a Professor of Microbiology, Immunology & Molecular Genetics and Professor of Bioengineering at the California NanoSystems Institute of UCLA. Dr. Soon-Shiong received the Franklin Institute Award in 2016 and, in 2017, the Smithsonian Institute honored his work by placing Abraxane in the permanent exhibit at the National Museum of American History. In 2018, he became Owner and Executive Chairman of the Los Angeles Times and San Diego Union-Tribune.
Born and raised during apartheid in South Africa, Dr. Soon-Shiong resides in Los Angeles and is a citizen of the United States.